Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ghermaoui S"'
Autor:
Moussa A, Cécile Faure-Conter, Picot S, Sabourin-Cousin M, Stéphanie Puget, Anne-Isabelle Bertozzi, Lechapt-Zalcman E, Emilie Barret, M-A Debily, Arnault Tauziède-Espariat, Klas Blomgren, Jacques Grill, Gilles Vassal, Natacha Entz-Werle, De Carli E, Karsten Nysom, Pascale Varlet, Thomas Kergrohen, Kevin Beccaria, Chappe C, Ghermaoui S, David Castel, Le Teuff G, P. Leblond
Diffuse intrinsic pontine gliomas (DIPG) is an incurable neoplasm occurring mainly in children for which no progress was made in the last decades. The randomized phase II BIOMEDE trial compared three drugs (everolimus, dasatinib, erlotinib) combined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d90bbc391315a6f62a0b2a5700d6c3
https://doi.org/10.1101/2021.04.29.21256183
https://doi.org/10.1101/2021.04.29.21256183
Autor:
Bruschi M; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Midjek L; Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Ajlil Y; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Vairy S; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Lancien M; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Ghermaoui S; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Kergrohen T; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Verreault M; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., de Biagi CAO Junior; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Broad Institute of MIT and Harvard, Cambridge, USA., Liu I; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Broad Institute of MIT and Harvard, Cambridge, USA., Filbin MG; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.; Broad Institute of MIT and Harvard, Cambridge, USA., Beccaria K; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France., Blauwblomme T; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France., Puget S; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France., Tauziede-Espariat A; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, ParisFrance.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR 1266, INSERM, IMA-BRAIN, Université de Paris, Paris, France., Varlet P; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, ParisFrance.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR 1266, INSERM, IMA-BRAIN, Université de Paris, Paris, France., Dangouloff-Ros V; Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, ParisFrance., Boddaert N; Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, ParisFrance., Le Teuff G; Department of Biostatistics and Epidemiology, Gustave Roussy and Paris-Saclay University, Villejuif, France., Grill J; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Montagnac G; Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Elkhatib N; Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France., Debily MA; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Biologie, Université Evry Paris-Saclay, Evry, France., Castel D; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Mar 04; Vol. 26 (3), pp. 553-568.
Autor:
Castel D; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France. david.castel@gustaveroussy.fr.; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France. david.castel@gustaveroussy.fr., Kergrohen T; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France.; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Tauziède-Espariat A; Department of Neuropathology, GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital, Paris, France.; Université de Paris, Paris, France., Mackay A; Divisions of Molecular Pathology, The Institute of Cancer Research, London, UK., Ghermaoui S; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France., Lechapt E; Department of Neuropathology, GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital, Paris, France.; Université de Paris, Paris, France., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Center Goettingen, Goettingen, Germany., Boddaert N; Department of Pediatric Radiology, IMAGINE Institute, INSERM UMR 1163, INSERM U1000, Hôpital Necker-Enfants Malades, Université de Paris, Paris, France., Blauwblomme T; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, APHP, Université de Paris, Paris, France., Puget S; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, APHP, Université de Paris, Paris, France., Beccaria K; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France.; Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, APHP, Université de Paris, Paris, France., Jones C; Divisions of Molecular Pathology, The Institute of Cancer Research, London, UK., Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Varlet P; Department of Neuropathology, GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital, Paris, France.; Université de Paris, Paris, France., Grill J; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France.; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Debily MA; Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 114 rue Édouard Vaillant, Villejuif, 94800, France. marie-anne.debily@gustaveroussy.fr.; Département de Biologie, Univ. Evry, Université Paris-Saclay, 23 boulevard de France, Evry, 91000, France. marie-anne.debily@gustaveroussy.fr.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2020 Jun; Vol. 139 (6), pp. 1109-1113. Date of Electronic Publication: 2020 Mar 19.